What is KYNB's P/E ratio?

KYNTRA BIO, INC. (KYNB) currently trades at a P/E ratio of 0.15.

KYNTRA BIO, INC. reports a Return on Equity (ROE) of -373.52%.

What is KYNB's dividend yield?

KYNTRA BIO, INC. offers a dividend yield of 0.00%.

What is KYNB's Deepscope Quality Score?

Deepscope rates KYNB's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy KYNB?

Deepscope's AI Timing Score for KYNB is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does KYNB belong to?

KYNTRA BIO, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-16 | FS: 2026-03-31)

KYNB

KYNTRA BIO, INC.

US:NASDAQ STOCK Healthcare >> Biotechnology News 86

USD 6.91

0.04 (0.58%) Day Change

Watchlist Portfolio Compare Chart

0.15

P/E

-3.21

D/E

-373.5%

ROE

149.2%

ROA

0.00%

Div Yield

KYNTRA BIO, INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.91 Price 0.04 (0.58%) Day Change	NEWS SCORE: 86

KYNB, ค่าปัจจัยพื้นฐานยังไม่ดีนัก ( คะแนนปัจจัยพื้นฐาน = 54) และ ค่าปัจจัยทางเทคนิค ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ต่ำกว่าเกณฑ์
อัตราการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ในปีก่อน เป็นลบ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนสินทรัพย์ (ROA) ต่ำกว่าเกณฑ์
อัตราการเติบโตของอัตราผลตอบแทนสินทรัพย์(ROA) ปัจจุบันต่ำกว่าเกณฑ์
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ พอใช้ สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร พอใช้ , ...

ปัจจัยทางคุณภาพ

67%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	86
Magic Formula Rank by ROA	4 GREAT
Magic Formula Rank by ROE	4 GREAT
Magic Formula Rank by ROIC	2 GREAT
Price	6.91
PBV / Sector	-0.90 / 4.95
Earning Per Share	40.89

PE / Sector	0.15 / 18.38 GREAT
PEG or PE/Growth / Sector	N/A / 0.62
Average 1M Daily Value	0.22 M GREAT
Average 1W Daily Value	0.70 M GREAT

ปัจจัยทางเทคนิค

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

68%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	2,199.42 / 468.85 GOOD
NPM Average (%) / Sector	814.30 / -1,531.69 GREAT
NPM Change Average (%) / Sector	-444.69 / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	149.24 / 31.69 GREAT
ROA Average (%) / Sector	33.04 / -353.18 GREAT
ROA Change Average (%) / Sector	-205.47 / 5,214.65
ROE (%) / Sector	-373.52 / 10.58
ROE Average (%) / Sector	109.05 / 27.64 GREAT
ROE Change Average (%) / Sector	-802.35 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ปันผล

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.27

ข้อมูลการจดทะเบียน

Analyze Date	2026-06-17 09:51:11
Symbol	KYNB
Name	KYNTRA BIO, INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	4.05 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	27.65 / 9,028.40

ข่าว

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 350 Bay Street, San Francisco, CA, United States, 94133

Phone: 415 978 1200

Website: https://www.kyntrabio.com

Sector: Healthcare >> Biotechnology

Description: Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. It is also developing Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.